Trial Profile
Efficacy of single dose intranasal dexmedetomidine for conscious sedation in dental practice in dentophobic uncooperative patients with intellectual disability.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- Acronyms KUKIDEX-2
- 20 Dec 2016 New trial record